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Mdm2 is an E3 ubiquitin ligase that targets p53 for
degradation.p53515C (encoding p53R172P) is a hypo-
morphic allele of p53 that rescues the embryonic
lethality of Mdm2/ mice. Mdm2/ p53515C/515C
mice, however, die by postnatal day 13 resulting
from hematopoietic failure. Hematopoietic stem cells
and progenitors of Mdm2/ p53515C/515C mice were
normal in fetal livers but were depleted in postnatal
bone marrows. After birth, these mice had elevated
reactive oxygen species (ROS) thus activating
p53R172P. In the absence of Mdm2, stable
p53R172P induced ROS and cell cycle arrest, senes-
cence, and cell death in the hematopoietic compart-
ment. This phenotype was partially rescued with
antioxidant treatment and upon culturing of hemato-
poietic cells in methycellulose at 3% oxygen. p16
was also stabilized because of ROS, and its loss
increased cell cycling and partially rescued hemato-
poiesis and survival. Thus, Mdm2 is required to
control ROS-induced p53 levels for sustainable
hematopoiesis.
INTRODUCTION
Hematopoietic stem cells (HSCs) are the ultimate reservoir that
replenish the blood with new cells of all lineages throughout an
organism’s lifetime (Orkin and Zon, 2008). HSCs emerge at
distinct sites throughout development, a journey that is highly
conserved among mammalian species. Primitive hematopoiesis
and the HSC precursors first appear in the yolk sac at embryonic
day (E) 7.5 in the mouse (Palis et al., 1995, 1999). The fetal liver
constitutes the major organ for embryonic HSC expansion and
definitive hematopoiesis before HSCs engraft the bone marrow606 Cell Stem Cell 7, 606–617, November 5, 2010 ª2010 Elsevier Incand establish it as their major niche throughout the rest of organ-
ism’s life (Muller-Sieburg et al., 1986).
Reactive oxygen species (ROS) are generated by intrinsic or
extrinsic sources, such as oxidative metabolism and ionizing
radiation, respectively, and can cause DNA damage (Lombard
et al., 2005; Naka et al., 2008). ROS levels distinguish HSC
self-renewal capacity. Specifically, HSCs with lower ROS levels
can engraft irradiated recipients better than HSCs with higher
ROS content (Jang and Sharkis, 2007). Genes involved in
ROS-induced DNA damage can also regulate HSC self-renewal.
For instance, Atm loss induces ROS production by unknown
mechanisms, which activates the p16INK4a-retinoblastoma
pathway and abrogates HSC self-renewal (Ito et al., 2004,
2006). The hematopoietic phenotype is rescued upon treatment
with antioxidants (Ito et al., 2004). Altogether, these studies
suggest a strong influence of ROS on HSCs.
p53 is a transcription factor that activates a plethora of genes
whose products induce cell cycle arrest, differentiation, senes-
cence, and apoptosis in response to DNA damage signals
such as ROS (Ko and Prives, 1996; Vazquez et al., 2008).
Mdm2 is an E3 ubiquitin ligase and the major negative regulator
of p53 stability (Honda et al., 1997).Mdm2/mice die embryon-
ically but nullizygosity of p53 completely rescues this phenotype
(Jones et al., 1995; Montes de Oca Luna et al., 1995).Mdm2/
p53/mice, like p53/mice, die by8months of age because
of tumor burden and do not appear to have hematopoietic
defects (McDonnell et al., 1999). Additionally, conditional loss
of both Mdm2 alleles in various adult tissues leads to cardiac,
intestinal, and lymphoid defects resulting from constitutively
active p53 (Marine et al., 2006).
A rare p53mutation (arginine to proline) in human p53 at amino
acid 175 lacks apoptotic activity but still maintains cell cycle
arrest activity (Ludwig et al., 1996; Rowan et al., 1996). Our lab
previously generated a knockin p53515C allele in the mouse
that encodes p53R172P protein mimicking this human mutation
(Liu et al., 2004). Homozygosity of the p53515C allele also rescues
theMdm2 null phenotype, butMdm2/ p53515C/515Cmice suffer
from hematopoietic defects and succumb to early postnatal.
Figure 1. Mdm2–/– p53515C/515C Mice Die
Postnatally because of Hematopoietic
Failure
(A) Kaplan-Meier survival curves of Mdm2/
p53515C/515C, Mdm2+/ p53515C/515C, and
Mdm2+/+ p53515C/515C mice.
(B) Representative H&E staining of fetal livers (FL)
at E14.5 and bone marrows (BM) at E18.5, P6, P8,
and P10 from Mdm2+/ p53515C/515C (left) and
Mdm2/ p53515C/515C (right) mice. Scale bars
represent 200 mm.
(C) Immunohistochemical staining of p53R172P
on paraffin-embedded sections of E14.5 fetal
livers, and E18.5, P6, P8, and P10 bone marrows
from Mdm2+/ p53515C/515C (left) and Mdm2/
p53515C/515C (right) mice. Scale bars represent
50 mm.
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Mdm2 Is Indispensible for Hematopoiesismortality (Liu et al., 2007). Restoration of one Mdm2 allele
(Mdm2+/ p53515C/515C) completely rescues hematopoiesis and
survival. A mechanistic understanding of the role of p53 in hema-
topoiesis is unclear.
In this study, we show that despite the absence of Mdm2,
p53R172P is not stabilized during embryogenesis until E18.5
when hematopoiesis proceeds in the bone marrow. HSCs are
under higher oxidative stress in the bone marrow than fetal liver
stabilizing and activating p53R172P in the bone marrow. Subse-
quently, p53R172P induced ROS and cell cycle arrest, senes-
cence, and cell death in the hematopoietic compartment of
Mdm2/ p53515C/515C mice. Hematopoiesis was rescued
when mice or cells were exposed to lower oxidative stress.
Finally, ROS also activated p16, and genetic ablation of p16
increased bone marrow cycling and cellularity, increased
survival, and partially rescued HSCs and progenitors. Thus,
oxidative stress was the intrinsic signal that activates p53 in
hematopoietic tissues, and HSCs and progenitors are highly
sensitive to p53 response. In summary, Mdm2 is required forCell Stem Cell 7, 606–617, Nsurvival of HSCs and sustainability of
hematopoiesis via downregulation of
p53’s response to basal ROS levels.
RESULTS
Characterization of the Mdm2–/–
p53515C/515C Hematopoietic
Phenotype
Mdm2/ p53515C/515C and Mdm2+/
p53515C/515C (control) mice were gener-
ated from the same litter by breeding
Mdm2+/ p53515C/515C mice to each
other. Mdm2/ p53515C/515C mice were
born at normalMendelian ratio (Figure 1A)
andwere indistinguishable from their con-
trol littermates at birth. However, by post-
natal day (P) 5, Mdm2/ p53515C/515C
mice became visually discernible from
their littermates by their smaller size. All
Mdm2/ p53515C/515C mice died by P13
(Figure 1A). Analysis of tissues fromMdm2/ p53515C/515C neonates revealed severe hematopoietic
defects (Figure 1B). Because Mdm2/ p53515C/515C were born
with no obvious defects, we hypothesized that hematopoiesis
was normal during embryogenesis. Indeed, hematoxylin and
eosin (H&E) sections of fetal livers at E14.5 and bone marrows
at E18.5 confirmed normal cellularity and histology compared
to Mdm2+/ p53515C/515C littermate controls (Figure 1B). By P6,
bone marrow cellularity begins to fall to 60%–70% of control.
The bone marrow becomes almost acellular at P10 (<10%
cellularity) (Figure 1B).
Because Mdm2 targets p53 for degradation, we performed
immunohistochemisty (IHC) on hematopoietic tissues at various
time points to investigate p53R172P levels. E14.5 fetal livers of
Mdm2+/ p53515C/515C and Mdm2/ p53515C/515C mice had
very low levels of p53R172P staining and were indistinguishable
(Figure 1C). On the other hand, bone marrow cells of Mdm2/
p53515C/515C mice had elevated p53R172P staining at E18.5,
P6, P8, and P10. Control Mdm2+/ p53515C/515C littermates
were negative for p53R172P at all time points except for a fewovember 5, 2010 ª2010 Elsevier Inc. 607
Figure 2. p53R172P Transcriptional Activity Induces Cell Cycle Arrest and Senescence
(A) Expression levels of p53-regulated cell cycle (Ccng1, p21) and apoptosis (Perp, Puma, and Noxa) genes were measured by real-time RT-PCR from RNA of
whole bone marrows (WBM) at P6 and were normalized to Gapdh levels.
(B) Expression levels of senescence markers at P6 of whole bone marrow (WBM) RNA was measured by real-time RT-PCR and was normalized toGapdh levels.
(C) Percent of SA-bgal-positive cells of total P6-P8 whole bone marrows.
(D and E) Cell cycle analysis of E14.5 whole fetal livers (WFL) (D) and P6 whole bone marrow (WBM) (E) via propidium iodide on fixed cells of these tissues.
(F) Cleaved caspase-3 immunohistochemical staining on paraffin-embedded bone marrows ofMdm2+/ p53515C/515C (left) andMdm2/ p53515C/515C (right) at
P6 and P8. Insert is positive control. Scale bars represent 50 mm.
Error bars represent standard error of the mean. Sequences of primers used in (A) and (B) are listed in Table S1. See also Figure S1.
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Mdm2 Is Indispensible for Hematopoiesisp53R172P positively stained cells (Figure 1C). Hence, high
p53R172P levels correlated with decreased bone marrow cellu-
larity. This phenotype is p53R172P dependent as shown by the
fact that deletion of one p53 allele rescues the early postnatal
lethality (Liu et al., 2007). We repeated these crosses and
observed thatMdm2/ p53/515Cmice were born at the correct
Mendelian ratio. Mdm2/ p53/515C mice were sacrificed at
6 months of age without further analysis. In all assays (see
below), Mdm2+/ p53515C/515C were indistinguishable from
Mdm2+/+ p53515C/515C mice.p53R172P Activated Cell Cycle Inhibitors
and to a Lesser Extent Apoptotic Targets in Postnatal
Bone Marrows
Although E14.5 fetal livers showed normal histology and no
p53R172P staining, bone marrows of P6 moribund mice had
stable p53R172P levels (Figures 1B and 1C). Most importantly,
P6 bonemarrowsmaintained 60%–70%bonemarrow cellularity
(Figure 1B), providing us with enough cells for mechanistic
studies. Therefore, we chose E14.5 fetal livers and P6 bone mar-
rows as representative time points for detailed molecular char-
acterization of the embryonic and neonatal phenotypes, respec-
tively. We isolated RNA from whole fetal livers at E14.5 and
examined cell cycle arrest targets of p53: p21 and Ccng. p21608 Cell Stem Cell 7, 606–617, November 5, 2010 ª2010 Elsevier Incand Ccng mRNA levels were not significantly different between
Mdm2/ p53515C/515C and control Mdm2+/ p53515C/515 fetal
livers (Figure S1A available online). We also examined the
apoptosis targets of p53 and found no differences in induction
of Noxa, Perp, or Puma in fetal livers of Mdm2/ p53515C/515C
compared to Mdm2+/ p53515C/515C mice (Figure S1A). On the
other hand, all Mdm2/ p53515C/515C whole bone marrows at
P6 had dramatic and significant induction of p53 cell cycle
targets Ccng (9-fold) and p21 (43-fold) compared to control
Mdm2+/ p53515C/515C littermates (Figure 2A). As for apoptotic
targets, Puma and Noxa levels were consistently 2-fold higher
in Mdm2/ p53515C/515C moribund mice than in Mdm2+/
p53515C/515C mice (p < 0.02) (Figure 2A). Perp levels were the
same in all mice (Figure 2A).Increased Senescence inMdm2–/– p53515C/515C P6 Bone
Marrows
p53R172P protein also induces senescence in several mouse
models (Cosme-Blanco et al., 2007; Post et al., 2010). We there-
fore hypothesized that Mdm2/ p53515C/515C bone marrows in
early postnatal development may also exhibit a senescent
phenotype. Accordingly, in addition to p21, we examined
expression levels of other senescent markers Dcr2, p15, p16,
Dec1, and Pml via RT-PCR (Collado et al., 2005; Collado and.
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Mdm2 Is Indispensible for HematopoiesisSerrano, 2006). Expression levels of these genes in E14.5 whole
fetal liver cells were the same between Mdm2/ p53515C/515C
embryos and controls (Figure S1B). In P6 bone marrows, p21
(43-fold), Dcr2 (17-fold), and p15 (11-fold) were highly elevated
in Mdm2/ p53515C/515C mice as compared to controls,
whereas Dec1, p16, and Pml mRNA levels did not change
(Figure 2B). We next examined senescence-associated b-galac-
tosidase (SA-b-gal) activity in freshly isolated postnatal bone
marrow cells. Approximately 11%ofMdm2/ p53515C/515C cells
were positive for SA-b-gal compared to less than 5% for control
littermates (p = 0.0071) (Figure 2C; Figure S1C).
Decreased Cycling and Increased Cell Death
in Postnatal Bone Marrows of Mdm2–/– p53515C/515C
To investigate the cell cycle pattern in fetal livers and postnatal
bone marrows, we fixed cells from these tissues and analyzed
for DNA content. Cell cycle patterns of E14.5 fetal livers between
Mdm2/ p53515C/515C and Mdm2+/ p53515C/515C littermates
were indistinguishable as expected (Figure 2D). Specifically,
53%, 28%, and 16% of whole fetal liver cells in Mdm2/
p53515C/515C embryos were in G1, S, G2/M phase similar to
53%, 27%, and 16% in control Mdm2+/ p53515C/515C litter-
mates (Figure 2D). The fraction of cells in subG1 was less than
2% in both genotypes (Figure 2D).
P6 bone marrows, however, showed significant differences
between the two genotypes. Less than 6.5% of Mdm2/
p53515C/515C bone marrow cells were in S phase compared to
22% of control littermates (Figure 2E). Mdm2/ p53515C/515C
neonates had 7% of cells in G2/M compared to 13% in
Mdm2+/ p53515C/515C littermates (Figure 2E). A significant
percentage of Mdm2/ p53515C/515C bone marrow cells (15%)
as compared to <1% of control bone marrow cells were in
subG1 fraction, suggesting cell death as another mechanism
of depleting the cellular compartment (Figure 2E).
Because Puma and Noxa were elevated in Mdm2/
p53515C/515C P6 bone marrows, and because 15% of these cells
were in subG1, we investigated apoptosis as a mechanism for
depleting hematopoiesis. Except for a few positive cells, cas-
pase-3 staining was negative in all bone marrows at P6 and P8
by IHC (Figure 2F). We then used Annexin V staining as an alter-
nativemethod to examine apoptosis. E14.5 whole fetal livers and
P6 whole bone marrows of both Mdm2/ p53515C/515C and
Mdm2+/ p53515C/515C pups had less than 6% Annexin V-posi-
tive cells and differences between genotypes were statistically
insignificant (Figures S1D and S1E). Hence, although cell death
is occurring, the standard markers for apoptosis are negative,
suggesting an alternative mechanism of cell death.
p21 Loss Does Not Rescue Hematopoiesis but Extends
Lifespan ofMdm2–/– p53515C/515C Mice
p21 expression levels were the highest inMdm2/ p53515C/515C
bone marrows among all genes tested at P6 (Figure 2A). Also,
p21 maintains quiescence in HSCs (Cheng et al., 2000). Hence,
we hypothesized that p21 deletion might rescue hematopoiesis
by increasing proliferation and alleviating senescence of bone
marrows. Contrary to our expectations, however, Mdm2/
p53515C/515C p21/ mice suffered from acellular bone marrows
and succumbed to growth retardation (data not shown).
However, the median age and life expectancy were longer forCelthese mice indicating a partial rescue of postnatal lethality (Fig-
ure S1F). Increased survival may be due to effects on other
tissues as Mdm2/ p53515C/515C mice also suffer from multiple
defects (Liu et al., 2007).
Defective HSC and Progenitor Populations in Bone
Marrows of Mdm2–/– p53515C/515C Mice
HSCsare responsible for replenishing thecellular compartmentof
the blood. BecauseMdm2/ p53515C/515C bonemarrows reflect
absence of sustainable hematopoiesis,we hypothesized adefect
in the HSC and progenitor populations. We therefore examined
Lin ckit+ Sca1+ (LKS) and Lin ckit+ Sca1/low cell populations
that representHSCsandcommon lymphoid andmyeloid progen-
itors (CLP/CMP), respectively, at different time points (Morrison
and Weissman, 1994; Weissman and Shizuru, 2008).
E14.5 fetal livers of Mdm2/ p53515C/515C and Mdm2+/
p53515C/515C mice had normal LKS cell populations (0.236% and
0.24%) for Mdm2+/ p53515C/515C and Mdm2/ p53515C/515C
embryos, respectively, and normal CLP/CMP populations
(5.26% and 5.58%) for Mdm2+/ p53515C/515C and Mdm2/
p53515C/515C embryos, respectively (Figures 3A and 3B). This
was expected given the normal histology, absence of p53R172P
stability, and normal cell cycle of fetal livers at E14.5. However,
E18.5 bone marrows ofMdm2/ p53515C/515C embryos showed
significant decreases in LKS and CLP/CMP populations. Specifi-
cally, 0.117% and 0.508% of whole bone marrow cells are
LKS and CLP/CMP populations, respectively, in Mdm2/
p53515C/515C compared to 0.474% and 1.74%, respectively, in
Mdm2+/ p53515C/515C littermates at E18.5 (Figures 3A and 3B).
Postnatally, the differences were even more pronounced.
Specifically, at P4, LKS (0.044% in Mdm2/ p53515C/515C
versus 0.243% in control) and CLP/CMP (0.273% in Mdm2/
p53515C/515C versus 1.726% in control) populations were
dramatically low in bone marrows of Mdm2/ p53515C/515C
mice (Figures 3A and 3B). At P6, LKS and CLP/CMP levels drop-
ped further to <0.0103% and <0.075% of whole bone marrows,
respectively, although control Mdm2+/ p53515C/515C consis-
tently had significant higher levels (0.265% for LKS and
1.292% for CLP/CMP of whole bone marrow) (Figures 3A
and 3B). These populations became almost extinct by P8 in
Mdm2/ p53515C/515C mice (Figures 3A and 3B).
To further enrich for HSCs, we used two additional markers
(CD48 and CD150) with LKS, hereafter referred to as SLAM-
LKS (Kiel et al., 2005; Kim et al., 2006). 0.042% of Mdm2/
p53515C/515C fetal liver cells at E14.5 were SLAM-LKS whereas
0.036% forMdm2+/ p53515C/515C controls (p = 0.69) again, indi-
cating no differences at this embryonic stage (Figure 3C). P6
whole bone marrows showed >2-fold decrease in the SLAM-
LKS population inMdm2/ p53515C/515C (0.02%) bone marrows
as compared to Mdm2+/ p53515C/515C controls (0.047%)
(p = 0.02) (Figure 3D). Thus, regardless of mode for enriching
for HSCs, this population was decreased in bone marrows of
Mdm2/ p53515C/515C pups as compared to controls.
Ex Vivo Culture at 20% Oxygen Shows Absence
of Hematopoiesis during Embryonic and Postnatal
Development
To evaluate HSCs and CLP/CMP differentiation capacity ex vivo,
we used methylcellulose cultures. Colonies are identified basedl Stem Cell 7, 606–617, November 5, 2010 ª2010 Elsevier Inc. 609
Figure 3. HSC and Progenitors Are Not
Affected in Fetal Livers but Ebb Gradually
after Birth
(A) Percentage of LKS population of whole tissues
from E14.5 fetal livers (FL), and E18.5, P4, P6, P8,
and P10 bone marrows (BM). n > 3 for all samples.
(B) Percentages of CLP/CMP population of whole
tissues from same time points as in (A). n > 3 for
all samples.
(C and D) Percentage of SLAM-LKS cells of whole
fetal liver at E14.5 (C) and whole bone marrow at
P6 (D).
(E and F) Quantification of CFU-GM, BFU-E, and
GEMM colonies from methocult cultures of 20,000
Mdm2+/+ p53515C/515C, Mdm2+/ p53515C/515C,
and Mdm2/ p53515C/515C whole fetal liver (WFL)
cells (E) and whole bone marrow (WBM) (F) cells at
E14.5 and P2, respectively.
Error bars represent standard error of the mean.
See also Figure S2.
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Mdm2 Is Indispensible for Hematopoiesison morphology. Specifically, we looked for burst-forming unit
erythroid (BFU-E), colony-forming unit granulocyte macrophage
(CFU-GM), and colony-forming unit granulocyte erythroid
monocyte and megakaryocyte (GEMM) colonies. Mdm2/
p53515C/515C E9.5 yolk sacs, E14.5 fetal livers, and P2 bone
marrows showed no hematopoietic activity ex vivo, although
the same tissues from controlMdm2+/ p53515C/515C littermates
grew well in culture (Figures 3E and 3F; Figure S2). Noteworthy,
E14.5 fetal liver and P2 bone marrow of Mdm2+/+ p53515C/515C
hematopoietic activity in methocult showed no significant differ-
ences for all lineages compared to Mdm2+/ p53515C/515C
(Figures 3E and 3F). Thus, the ex vivo assays did not reproduce
our in vivo results showing normal LKS and CLP/CMP popula-
tions in Mdm2/ p53515C/515C fetal livers. These differences
suggested oxidative stress as an impediment for growth.
ROS Levels Are High in Mdm2–/– p53515C/515C Bone
Marrows
ROS are major sensitizers of the hematopoietic system (Naka
et al., 2008). Whether ROS effects are mediated via the p53
pathway in the hematopoietic compartment is unknown. To610 Cell Stem Cell 7, 606–617, November 5, 2010 ª2010 Elsevier Inc.examine ROS levels in fetal livers and
postnatal bone marrows, we used
5-(and-6)-carboxy-20,70-dichlorofluores-
cein diacetate (DCFDA). We chose E14.5
fetal liver and P6 bone marrow as repre-
sentative embryonic and postnatal time
points, respectively. ROS levels of whole
fetal livers and LKS populations at E14.5
between Mdm2+/ p53515C/515C and
Mdm2/ p53515C/515C mice were not
statistically different (Figures 4A and 4B).
Postnatally, mice are exposed to atmo-
spheric oxygen levels. Indeed, Mdm2+/
p53515C/515C whole bone marrows and
LKS populations had 3.8 and 1.5 times
more ROS, respectively, compared to
the same populations in E14.5 fetal livers(Figures 4A and 4B). This indicated that ROS levels within the
hematopoietic compartment were higher postnatally.
All pups are littermates, so we expected that ROS levels of
Mdm2+/ p53515C/515C and Mdm2/ p53515C/515C littermates
would be the same at P6. To our surprise, Mdm2/
p53515C/515C pups had 3.3 times higher ROS levels in whole
bone marrow compared to control (Figure 4A). ROS were also
higher in E18.5 bonemarrows as compared to fetal livers regard-
less of genotype (Figure S3A). ROS levels in the LKS population
of Mdm2/ p53515C/515C pups was consistently 3-fold
(p = 0.005) higher than Mdm2+/ p53515C/515C littermates in P6
bone marrows (Figure 4B; Figure S3B). The CLP/CMP popula-
tion of Mdm2/ p53515C/515C pups at P6 also had 3.6-fold
(p = 0.0009) higher ROS than control Mdm2+/ p53515C/515C
pups (Figure 4C). These data show that Mdm2/ p53515C/515C
bone marrows generated more ROS in LKS and CLP/CMP
populations.
We next investigated whether elevated ROS in postnatal bone
marrows compared to fetal livers was due to temporal (embry-
onic versus postnatal) or spatial (liver versus bonemarrow) differ-
ences. P6 livers and bonemarrows ofMdm2+/ p53515C/515C and
Figure 4. IncreasedROS Levels in Postnatal
BoneMarrows ofMdm2–/– p53515C/515CMice
(A) ROS levels were measured in whole tissues
(fetal livers [FL] and bone marrows [BM]) at E14.5
and P6 with DCFDA intensity as a readout.
(B) Measurement of ROS levels with DCFDA in
LKS populations of E14.5 fetal liver (FL) and P6
bone marrow (BM). See also Figure S3.
(C) ROS in CLP/CMP in P6 bone marrows. Fold
difference is relative to ROS levels of CLP/CMP
of Mdm2+/ p53515C/515C pups.
(D) Measurement of ROS levels in whole liver and
whole bone marrows in P6 pups. ROS levels of
Mdm2+/ p53515C/515C whole livers were set to 1.
(E and F) Measurement of transcript levels of Pig1,
Pig8, and Pig12 from whole bone marrow (WBM)
cells at P6 (E) and P10 (F) from Mdm2/
p53515C/515C compared to Mdm2+/ p53515C/515C
measured by real-time RT-PCR and normalized
to Gapdh levels.
Error bars represent standard error of the mean.
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their livers compared to bone marrows of same mice at P6
(Figure 4D). These data clearly demonstrated that the differences
seen in ROS between fetal livers and postnatal bone marrows
were due to temporal variation and not the bone marrow niche
per se.
Increased Expression of ROS-Inducing Genes
inMdm2–/– p53515C/515C Pups
To address what instigated higher rates of ROS in P6 bone
marrows of Mdm2/ p53515C/515C mice compared to controls,
we examined p53’s role in ROS. p53 can transactivate a set of
ROS-inducing genes dubbed p53-induced genes (PIG) that
lead to cell death (Polyak et al., 1997). Specifically, we examined
mRNA levels of Pig1, Pig8, and Pig12, the most highly induced
Pig genes (Polyak et al., 1997). Pig1 is a member of galectin
family that can stimulate superoxide production (Yamaoka
et al., 1995). Pig8 is induced after etoposide treatment and is
known to generate ROS (Lehar et al., 1996). Pig12 is a micro-
somal glutathione transferase homolog and is involved in redox
reactions (Lee and DeJong, 1999).
At P6, Pig1 and Pig8 levels were 2- (p = 0.01) and 3- (p <
0.0001) fold higher in Mdm2/ p53515C/515C bone marrows as
compared to control littermates (Figure 4E). Pig12 levels were
the same at P6. Because p53 activates Pig genes in a cascading
manner, we examined expression of these genes in P10 wholeCell Stem Cell 7, 606–617,bone marrows as well. Pig12 levels at
P10 were 2.8-fold higher (p = 0.01) in
moribund Mdm2/ p53515C/515C mice
as compared to control littermates
(Figure 4F). Pig1 (p = 0.49) and Pig8 (p =
0.07) levels were not statistically different
at P10 (Figure 4F).
NAC Injections Partially Rescue
HSC and CLP/CMP at P6 In Vivo
N-acetyl Cysteine (NAC) is an antioxidant.
Because Mdm2/ p53515C/515C mice
lose their HSCs and die by P13, we injected pups at P3 and P5
with NAC. Unfortunately, this technique was highly invasive and
most pups of all genotypes died after the first injection. However,
twoMdm2+/ p53515C/515C and twoMdm2/ p53515C/515C pups
survived and were sacrificed at P6 to examine HSC and CLP/
CMP populations. A modest but significant increase in both of
these populations was prominent in Mdm2/ p53515C/515C
pups injected with NAC compared to untreated mice of same
genotype (Figures 5A and 5B). Specifically, there was a 4-fold
(p = 0.001) increase in LKS population of whole bone marrow
and 7-fold (p = 0.01) increase in CLP/CMP population of whole
bone marrow in treated versus untreated mice (Figures 5A and
5B). The two Mdm2+/ p53515C/515C pups treated with NAC that
survived had no significant differences in HSC and CLP/CMP
populations compared to untreated genotype-matched mice
(Figures 5A and 5B). Notably, a third Mdm2/ p53515C/515C
mouse that survived two injections of NAC received a third injec-
tion at P7 andwas sacrificed at P10. Bonemarrow cellularity was
80% restored in the treated mouse compared to theMdm2/
p53515C/515C untreated control (Figure 5C).
These data suggest that ROS contributes to the hematopoietic
defect in Mdm2/ p53515C/515C mice. Our initial ex vivo assays
were performed at 20% oxygen. We therefore examined
hematopoiesis ex vivo at 3% oxygen levels. Specifically, cells
from E14.5 fetal livers and P2 bone marrows of the same pups
used in Figures 3C and 3D were plated onto methycellulose.November 5, 2010 ª2010 Elsevier Inc. 611
Figure 5. Rescue of Hematopoietic Defects upon Treatment with NAC or Culturing at 3% Oxygen
(A and B) LKS (A) and CLP/CMP (B) populations of whole bone marrows at P6 for NAC-treated and untreated mice.
(C) Representative H&E staining for P10 bone marrow of aMdm2/ p53515C/515Cmouse treated with NAC (right) compared to untreated (left). Scale bars repre-
sent 200 mm.
(D and E) 20,000 cells of Mdm2+/ p53515C/515C and Mdm2/ p53515C/515C whole fetal livers (WFL) and whole bone marrow (WBM) cells were cultured at 3%
oxygen and the number of CFU-GM, BFU-E, and GEMM colonies were quantified.
(F) Survival curve of CD45.1 mice transplanted with 0.5 3 106 Mdm2+/ p53515C/515C orMdm2/ p53515C/515C whole bone marrow cells, supplemented with or
without NAC in drinking water.
(G) Percent of donor-derived CD45.2 cells from peripheral blood assay at 5–6 weeks after transplantation.
Error bars represent standard error of the mean. See also Figure S4.
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Figure 6. p16 Is Stabilized in Mdm2–/– p53515C/515C Bone Marrows and Its Loss Rescues Bone Marrow Cellularity
(A) Immunohistochemical staining of p16 in P6, P8, and P10 bone marrows of Mdm2+/ p53515C/515C (left) and Mdm2/ p53515C/515C (right) mice. Hematoxylin
(blue) is nuclear counterstain. Scale bars represent 50 mm.
(B) Immunofluorescence staining of P8 bone marrows for p16 with a different antibody than (A). Arrows indicate cytoplasmic or nuclear staining.
(C) H&E staining of P10 bone marrows from Mdm2/ p53515C/515C (left) and Mdm2/ p53515C/515C p16/ (right) mice. Scale bars represent 200 mm.
(D) Percentage of bone marrow cellularity of Mdm2/ p53515C/515C p16/ mice compared to Mdm2+/ p53515C/515C p16/ littermates at P10.
(E) Kaplan-Meier survival curve of Mdm2/ p53515C/515C p16/ mice (n = 15) compared to Mdm2/ p53515C/515C mice (n = 26).
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allowed hematopoiesis to proceed unimpeded and allMdm2/
p53515C/515C tissues formed CFU-GM, BFU-E, and GEMM indis-
tinguishable from controls Mdm2+/ p53515C/515C (Figures 5D
and 5E). Hence, all Mdm2/ p53515C/515C fetal livers and P2
bone marrows examined showed complete rescue of hemato-
poiesis in methylcellulose cultures at 3% oxygen. These data
indicate that oxidative stress was the major impediment for
sustainable hematopoiesis in the absence of Mdm2 resulting
from activation of p53R172P.
WBM of P6 Mdm2–/– p53515C/515C Mice Cannot Rescue
Lethally Irradiated Mice
To measure reconstitution capacity of Mdm2/ p53515C/515C
HSCs, we transplanted 0.5 3 106 whole bone marrow
cells from CD45.2 P6 Mdm2+/ p53515C/515C and Mdm2/
p53515C/515C pups into lethally irradiated CD45.1 congenic mice
and monitored survival and engraftment. Eight of eight mice
transplanted with Mdm2+/ p53515C/515C WBM survived at least
45 days (end point of the experiment), whereas 8/8 mice trans-
planted with Mdm2/ p53515C/515C died within 12 days after
lethal irradiation (Figure 5F). Surviving mice had at least 85%
donor-derived (CD45.2) cells, confirming that P6 WBM ofCelMdm2+/ p53515C/515C can engraft and reconstitute hematopoi-
esis for lymphoid and myeloid lineages (Figure 5G; Figures S4A
and S4D). We then supplemented NAC in drinking water of
another cohort of recipient mice to address whether antioxidant
treatment could rescueMdm2/ p53515C/515CHSC activity. Five
of five recipient mice transplanted with Mdm2/ p53515C/515C
WBM and provided with NAC did not survive (Figure 5F).
p16 Deletion Partially Rescues Bone Marrow Cellularity
and Extends Survival ofMdm2–/– p53515C/515C Mice
p16 is activatedbecauseofROS (Ito et al., 2004). ROS levelswere
elevated in Mdm2/ p53515C/515C bone marrows, so we exam-
ined p16 status. Although p16 mRNA levels were indistinguish-
able between Mdm2/ p53515C/515C and control littermates at
P6 (Figure 2B), we detected significantly elevated p16 protein
levels by IHC at P6, P8, and P10 and by immunofluorescence
at P8 in Mdm2/ p53515C/515C bone marrows via two different
antibodies (Figures 6A and 6B). Bone marrows of control
Mdm2+/ p53515C/515C littermates had some positive cells for
p16 staining but much less than Mdm2/ p53515C/515C mice
(Figures 6A and 6B).
To address whether p16 deletion can restore hematopoiesis,
we generated Mdm2+/ p53515C/515C p16/ mice and crossedl Stem Cell 7, 606–617, November 5, 2010 ª2010 Elsevier Inc. 613
Figure 7. Partial Rescue of LKS and CLP/CMP Populations in Mdm2–/– p53515C/515C p16–/– Mice
(A) p53R172P immunohistochemical analysis on P10 bone marrows (BM) of Mdm2/ p53515C/515C (left) and Mdm2/ p53515C/515C p16/ (right) mice. Scale
bars represent 50 mm.
(B) Cell cycle status of P6 whole bone marrow cells (WBM) of Mdm2/ p53515C/515C mice with and without p16.
(C and D) LKS (C) and CLP/CMP (D) populations of P6 whole bone marrow of Mdm2/ p53515C/515C p16/ mice compared to Mdm2/ p53515C/515C mice.
(E) Suggested model for activation of p53 during hematopoiesis postnatally. Error bars represent standard error of the mean.
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normal and their pregnancy rate was low, they were still able to
generate pups. Three Mdm2/ p53515C/515C p16/ mice from
two independent crosses sacrificed at P10 (where bone marrow
acellularity is most dramatic in Mdm2/ p53515C/515C mice)
showed restoration of bone marrow cellularity by at least 80%
(Figures 6C and 6D). Also, Mdm2/ p53515C/515C p16/
mice lived significantly (p < 0.0001) longer than Mdm2/
p53515C/515C mice (Figure 6E).
Mdm2–/– p53515C/515C p16–/– Bone Marrows Have
Increased LKS and CLP/CMP Populations Compared
to Mdm2–/– p53515C/515C Bone Marrows
In order to examine the mechanism behind rescue of bone
marrow cellularity upon genetic deletion of p16, we first exam-
ined p53R172P levels in Mdm2/ p53515C/515C p16/ bone
marrows by IHC at P10. p53R172P was still high in Mdm2/
p53515C/515C p16/ bone marrows (Figure 7A). We then614 Cell Stem Cell 7, 606–617, November 5, 2010 ª2010 Elsevier Incexamined the cell cycle status of Mdm2/ p53515C/515C
p16/ bone marrows at P6. The fraction of cells in Mdm2/
p53515C/515C p16/ bone marrows that were in S phase
was 2-fold higher (12.9%) than bone marrows of Mdm2/
p53515C/515C mice (6.5%) (Figure 7B). The subG1 population in
Mdm2/ p53515C/515C p16/ bone marrows was not signifi-
cantly different from Mdm2/ p53515C/515C bone marrows.
This indicated that increased bone marrow cycling contributed
to rescue of bone marrow cellularity.
We then analyzed the LKS and CLP/CMP populations of
Mdm2/ p53515C/515C p16/ mice compared to Mdm2/
p53515C/515C bone marrows at P6. There was a significant
increase in both of these populations. Specifically, LKS popula-
tions increased by 4-fold to 0.0413% in whole bone marrow
upon deletion of p16 compared to 0.0103% in Mdm2/
p53515C/515C mice (Figure 7C). CLP/CMP levels increased
9-fold upon deletion of p16 and reached 0.686% of whole
bone marrow (Figure 7D). Although LKS and progenitor levels.
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this increase was consistent and can explain the replenishment
of bone marrow cellularity at P10 (Figure 6C). Mdm2+/
p53515C/515C p16/ bone marrows had no significant changes
in LKS or CLP/CMP populations compared to Mdm2+/
p53515C/515C bone marrows (Figures 7C and 7D).
DISCUSSION
Mdm2 is a potent inhibitor of p53 activity. Loss ofMdm2 in mice
leads to an embryo lethal phenotype that is p53 dependent
(Jones et al., 1995; Montes de Oca Luna et al., 1995). Tissue-
specific deletion of Mdm2 and studies with hypomorphic alleles
have shed light on the importance of maintaining low p53 levels
in numerous adult tissues as well (Marine et al., 2006; Mendrysa
et al., 2003; O’Leary et al., 2004; Ringshausen et al., 2006; Za-
fon, 2007). In this study, we utilized the p53515C hypomorphic
allele, which in anMdm2 null background leads to severe hema-
topoietic defects that occur postnatally. In this model, the
p53R172P protein is activated in bone marrows at late embryo-
genesis and postnatally but not in fetal livers by E14.5, suggest-
ing that intrinsic signals activate p53 in a tissue-specific
manner. p53R172P activity impeded hematopoiesis via induc-
tion of cell cycle arrest, senescence, and ultimately cell death
in HSCs and progenitors. The defect seen in Mdm2/
p53515C/515C HSCs is intrinsic, as shown by the fact that these
cells failed to rescue lethally irradiated wild-type mice. This
hematopoietic defect is p53 dependent, as shown by the fact
that loss of a single p53515C allele completely rescues the
phenotype. In other models, wild-type p53 also causes hemato-
poietic defects emphasizing the relevance of studying our
model (Terzian et al., 2007). Thus, Mdm2 functions as a major
contributor to keeping p53 levels low. In contrast, HSCs lacking
p53 exit quiescence and show increased cycling (Liu et al.,
2009a). Balancing p53 levels is thus crucial for cellular
homeostasis.
Several studies suggest a direct role of ROS in regulation of
HSC fate. For instance, ATM-mediated inhibition of oxidative
stress maintains HSC self-renewal capacity (Ito et al., 2004). In
Drosophila, higher ROS levels sensitize common myeloid
progenitors to differentiation (Owusu-Ansah and Banerjee,
2009). We therefore examined ROS levels as a possible intrinsic
signal for activation of p53 and showed that whole bonemarrows
and HSCs had increased ROS levels as compared to fetal livers
possibly because of accumulation of ROS from metabolic prod-
ucts during development and direct exposure to atmospheric
oxygen. Increased ROS have also been implicated in cellular
senescence as observed in our mouse model (Chen et al.,
1995). Notably, the hematopoietic defect was rescued ex vivo
at lower oxygen culture conditions and in vivo by antioxidant
treatment. However, HSCs from Mdm2/ p53515C/515C mice
did not rescue lethally irradiated recipients supplemented with
NAC possibly because ROS levels were too high for the dose
of NAC used. Other studies have shown p16 activation resulting
fromROS in bonemarrows (Ito et al., 2004; Liu et al., 2009b). p16
deletion rescues hematopoiesis by inducing higher cell cycling,
providing evidence for a direct link between ROS, p16, and
hematopoiesis. Importantly, p16 loss does not decrease p53
levels, implying that p16 functions in a complementary pathway.CelAlthough Mdm2/ p53515C/515C and Mdm2+/ p53515C/515C
pups were littermates, the former bone marrows showed signif-
icantly higher ROS levels than the latter at postnatal time points.
p53 directly induces production of ROS via transactivation of Pig
genes (Polyak et al., 1997). The Pig genes were also elevated in
this model, creating a positive feedback loop and abrogating
HSC function (Figure 7E). Other studies clearly demonstrate
that wild-type p53 can transactivate ROS-inducing genes (Don-
ald et al., 2001; Li et al., 1999; Polyak et al., 1997), so we believe
that the ROSproduction inMdm2/ p53515C/515C bonemarrows
is due to normal function of p53R172P. Notably, elevated ROS in
P6 bone marrows was not due to bone marrow niche per se but
more probably due to temporal accumulation of ROS.
In summary, our study sheds light on the importance of the
p53-Mdm2 pathway in hematopoiesis. In our model, basal
ROS levels accumulate in hematopoietic tissues during develop-
ment. Normally, the balance between Mdm2 and p53 is highly
regulated. In the absence ofMdm2 and in the presence of basal
oxidative stress, p53 activity increases. p53 instigates further
ROS production via transactivation of PIGs, creating a positive
feedback loop (Figure 7E). These processes deplete HSCs and
progenitors via induction of cell cycle arrest, senescence, and
ultimately cell death. Hence, caution is warranted when treating
patients with p53 reactivating drugs and/or Mdm2-p53 binding
inhibitors because such drugs can affect the hematopoietic
compartment and deplete hematopoietic stem cells/progeni-
tors. In contrast though, sensitization of bone marrows and
HSCs to the ROS-p53 pathway can be exploited in leukemias
because leukemia stem cells can arise from HSCs and both
share several characteristics (Passegue´ et al., 2003). Thus,
even during normal hematopoiesis, p53 is activated by stress
signals and Mdm2 is required to regulate p53 levels and allow
stem cell survival.EXPERIMENTAL PROCEDURES
Mice
We used previously describedMdm2+/ (Montes de Oca Luna et al., 1995) and
p53515C/515C (Liu et al., 2004) mice. Mdm2+/ p53515C/515C mice were bred to
each other to generate Mdm2/ p53515C/515C, Mdm2+/+ p53515C/515C, and
Mdm2+/ p53515C/515C littermates. All mice were at >90% C57BL/6 back-
ground as determined by marker analysis by Genetic Services at MDACC.
Genotyping was performed as previously described for p53515C (Liu et al.,
2004), Mdm2 (Montes de Oca Luna et al., 1995), p16 (Sharpless et al.,
2001), and p21 (Brugarolas et al., 1998). For antioxidant injections, NAC
(A7250, Sigma-Aldrich, MO, USA) was prepared in phosphate-buffered saline
and injected at P3 and P5 at 1 mg/g via a 28 gauge needle around the groin
region. Pups were sacrificed at P6. All animal studies were approved by the
Institutional Animal Care and Use Committee.
Histology and Immunostaining of Hematopoietic Tissues
Pregnant females were sacrificed at designated time points. Neonates were
decapitated. Tissues were either fixed in formalin for 48 hr and then paraffin
embedded for histological studies or processed for RNA isolation and stem
cell analysis. For tissues, slides were sectioned at 6 mm and stained with
hematoxylin and eosin by the Department of Veterinary Medicine and Surgery
Histology Service at MDACC. Antibodies used were: p53 (#CM5, Vector
Laboratories, CA, USA) at 1:500, p16 (#M-156, Santa Cruz Biotechnology,
CA, USA) at 1:50, and cleaved caspase-3 (#9661, Cell Signaling, MA, USA)
at 1:200 as previously described (Post et al., 2010). For p16 immunofluores-
cence, we used p16 conjugated to Alexa Fluor 647 (#F-12, Santa Cruz
Biotechnology).l Stem Cell 7, 606–617, November 5, 2010 ª2010 Elsevier Inc. 615
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Whole bone marrows from P6–P8 bone marrows were collected and cytospun
on slides. Cells were stained with Senescence b-Galactosidase Staining Kit
(#9860, Cell Signaling) according to manufacturer’s protocol. The number of
blue cells were counted in six random fields and averaged.
RNA Analysis
Bone marrows were homogenized and RNA was extracted with TRIzol
(#155-96-026, Invitrogen, MD, USA) and treated with DNase (#04716
728001, Roche, IN, USA) as previously described (Jackson and Pereira-
Smith, 2006). First-strand DNA was generated by using first-strand cDNA
synthesis kit from (#27-9261-01, GE Healthcare, NJ, USA). For Figures 2A,
2B, 4E, and 4F, bone marrows from two littermates of the same genotype
were combined to provide an adequate amount of tissue to produce suffi-
cient RNA for analysis. Primer sequences are in Table S1. All levels were
normalized to Gapdh.
Tissue Homogenization and Flow Cytometry
Tissues were washed with Hanks’ Balanced Salt Solution (#21-022-CV, Medi-
atech, Inc., VA, USA) supplemented with 2% fetal bovine serum (#S11150, At-
lanta Biologicals, GA, USA), 10 mM HEPES Buffer (#25-060, Mediatech) and
13 penicillin-streptomycin solution (#30-002, Mediatech), termed HBSS+.
Cells were kept in Dulbecco’s Modified Eagle Medium (DMEM) (#10-107, Me-
diatech) with supplements as described for HBSS+. Fetal livers were homog-
enized with 181/2 G needle and passed through a 40 mm filter (#342340, BD
Falcon, NJ, USA). Bones from fore limbswere cleaned ofmuscle and cartilage,
and marrows were finely chopped and filtered as above. For flow cytometry,
murine HSC and MPP were identified with eBioscience (CA, USA) fluoro-
chrome conjugated antibodies against ckit (PE_Cy7), Sca-1 (APC), and for
lineage depletion we used CD4 (PE), CD8a (PE), B220 (PE), Ter119 (PE), and
Gr-1 (PE) in HBSS+. For SLAM-LKS analysis, Lineage and Sca-1 markers
were used as described above (conjugated to PE and APC, respectively).
We also included CD48-PE (#12-0481, eBioscience), ckit-APC_CH7
(#560185, BDBioscience, NJ, USA), andCD150-PE_Cy7 (#115914, Biolegend,
CA, USA). Cells were stained for 20 min in the dark on ice then washed with
HBSS+ before analysis on BD LSRII System at MDACC Flow Cytometry
Core Facility. Dead cells were excluded with 7AAD or DAPI staining (eBio-
science). For ROS levels, cells were incubated with H2DCFDA (D-399,
Invitrogen) at 37C in the dark for 20 min at a final concentration of 1 nM after
LKS or CLP/CMP staining. Cells were then washed and kept to recover for
20 min at 37C in the dark.
Cell Cycle and Annexin V Analysis
Tissues were fixed with 70% ethanol and kept at 4C until stained with pro-
pidium iodide (#P3566, Invitrogen). Samples were analyzed on BD FACSCa-
libur System. Fetal livers and bone marrows were stained with FITC-conju-
gated Annexin V with ApoAlert Annexin V Apoptosis Kit (#630109,
Clontech, CA, USA) according to manufacturer’s protocol. Data were
analyzed on FlowJo.
Transplantation Experiments
C57/B6 CD45.1+ mice were irradiated with a split dose of 5.5 Gy 4 hr apart.
Two hours after the second dose, 0.5 3 106 whole bone marrow cells from
P6 Mdm2/ p53515C/515C and Mdm2+/ p53515C/515C mice were injected ret-
roorbitally into isofluorane-sedated mice. Mice were monitored for survival on
daily basis. For irradiation control, two mice were irradiated without transplan-
tation for each experiment. For engraftment analysis, mice were retroorbitally
bled 5 to 6 weeks posttransplantation and stained with CD45.1-FITC,
CD45.2-APC, Mac-1-PE, Gr-1-PE, CD3e-PE_Cy7, and CD45R/B220-
APC_780 from eBioscience.
Colony Forming Unit Assay
20,000 live cells were plated in triplicate from each tissue, grown in methylcel-
lulose media (#MethoCult M3434, STEMCELL Technologies, BC, Canada),
and maintained in minihumidity chambers in 20% or 3% oxygen tissue culture
incubators. Colonies were counted within 2 weeks of plating and identified
based on morphology.616 Cell Stem Cell 7, 606–617, November 5, 2010 ª2010 Elsevier IncStatistics
Two-way t test and Kaplan-Meier analyses were performed to assess statis-
tical difference. A factor was considered statistically significant if it had a p
value of <0.05.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and one table and can be
found with this article online at doi:10.1016/j.stem.2010.09.013.
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